Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01803594 · ClinicalTrials.gov registry record · NA
Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01803594: Completed NA study, sponsored by University of California, Davis.
NCT01803594 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01803594, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study involves measuring subject's blood lipid responses after they consume a mixture of dietary fats of marine and dairy origin and vitamin supplements mixed into a milkshake, on three separate days. The investigators hope to learn more about how different food ingredients influence the metabolism HDL in individuals with low blood levels of HDL cholesterol.
Primary Outcome
Plasma lipoprotein size distribution and concentration will be measured by nuclear magnetic resonance (NMR)
Interventions
- OTHER Control
- DIETARY_SUPPLEMENT Krill Oil
- DIETARY_SUPPLEMENT Lutein
- DIETARY_SUPPLEMENT Nicotinic acid
- DIETARY_SUPPLEMENT Dairy phospholipids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-03-13 |
| Phase | NA |
What the finished NCT01803594 record still lists
NCT01803594 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Control is the first listed.
NCT01803594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01803594 about?
NCT01803594 is a clinical study titled "Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism". This study involves measuring subject's blood lipid responses after they consume a mixture of dietary fats of marine and dairy origin and vitamin supplements mixed into a milkshake, on three separate days. The investigators hope to learn more about how different food ingredients influence the metabo...
What is the current status of trial NCT01803594?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-08. Estimated completion is 2015-03-13.
What interventions are being tested in trial NCT01803594?
The interventions under investigation include: Control (OTHER), Krill Oil (DIETARY_SUPPLEMENT), Lutein (DIETARY_SUPPLEMENT), Nicotinic acid (DIETARY_SUPPLEMENT), Dairy phospholipids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01803594?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01803594's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia